3 ASX Shares For The Crazy Rich Asian Boom

You have probably seen media reports lately on the rise of the Chinese middle class. Here are some ASX share ideas that could take advantage of this trend.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

You have probably seen media reports lately on the rise of the Chinese middle class. Here are some ASX share ideas that could take advantage of this trend.

The Rise Of The Middle Class

online pharmacy premarin no prescription

In 2002, China’s middle class (defined by spending $10-$50 a day) made up 4% of the population. 10 years later, the middle class was 31% of the population. On top of that, wage growth from 2001 to 2015 averaged 11% per annum. This gives Chinese consumers significantly higher disposable income than they had a decade ago. So, which Australian companies can take advantage of this?

Blackmores Ltd (ASX: BKL)

Blackmores, founded in the 1930s, is now Australia’s leading natural health company, operating brands like Blackmores, BioCeuticals, the Blackmores Institute, Fusion Health & Oriental Botanicals, and Impromy.

Looking at Blackmores’ recent quarterly update, they announced a fall in Australian and New Zealand revenue of 26% on the prior corresponding period. While this was disappointing, they also announced that Chinese revenue grew 19% in the same period driven by increased in-country and export sales.

Further, Blackmores stated they have “undertaken a major strategic review on how to maximise our Chinese consumer facing opportunity, including supporting daigou to more deeply engage with the Blackmores brand.

Blackmores also saw strong growth in Taiwan, Hong Kong, Korea and Malaysia. The results show that the Asian market will become increasingly important for Blackmores over the coming years.

The a2 Milk Company Ltd (ASX: A2M)

The a2 Milk Company had an impressive 1H19, reporting revenue growth of 41% and EBITDA growth of 52.7%.

While Australia and New Zealand revenue grew 37.5%, China & Other Asia revenue grew 50.1%. EBITDA growth in China was 41.6% for the half-year.

The main growth prospect for a2 Milk is infant formula sales in China. During the half, China label revenue grew 83%. Infant formula is a big focus for several of a2 Milk’s competitors as well, including Bellamy’s Australia Ltd (ASX: BAL).

With the growing demand in China, I think either of these two companies could be well-positioned to take a significant market share.

BetaShares Asia Technology Tigers ETF (ASX: ASIA)

For a slightly different approach, the BetaShares Asia Technology Tigers ETF could be worth considering. This tech-focussed ETF invests in the biggest Asian tech shares including Alibaba Group Holdings Ltd (NYSE: BABA) and Tencent Holdings Ltd

online pharmacy buy lexapro no prescription online pharmacy

(HKG: 0700). A growing middle class in China could lead to higher technology consumption as disposable income increases. With the sheer size of the population, Chinese technology companies are certainly companies to watch closely.

A word of warning: this ETF is relatively new and only opened for trade in September 2018, so it’s too early to really get a gauge of performance.

For other growth share ideas, check out the companies in the free report below.

2 Small-Cap Pocket Rockets

[ls_content_block id=”18457″ para=”paragraphs”]

Disclosure: At the time of writing, Max owns shares in BetaShares Asia Technology Tigers ETF (ASX: ASIA).

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.